AAAAAA

   
Results: 1-10 |
Results: 10
CLINICAL UTILITY OF AN AUTOMATED SERUM HER-2 NEU ASSAY IN MONITORING PATIENTS WITH METASTATIC BREAST-CANCER/
Authors: DAI J MORRIS DL NEAMAN IE CARNEY W TENNY D YEUNG KK ALLARD WJ CHAN DW SCHWARTZ MK
Citation: J. Dai et al., CLINICAL UTILITY OF AN AUTOMATED SERUM HER-2 NEU ASSAY IN MONITORING PATIENTS WITH METASTATIC BREAST-CANCER/, Clinical chemistry, 44, 1998, pp. 208-208
BCL-2 EXPRESSION AND DNA FRAGMENTATION IN BREAST-CARCINOMA, PATHOLOGICAL AND STEROID-HORMONE RECEPTORS CORRELATES
Authors: DIAZCANO SJ GARCIAMOLINER M CARNEY W WOLFE HJ
Citation: Sj. Diazcano et al., BCL-2 EXPRESSION AND DNA FRAGMENTATION IN BREAST-CARCINOMA, PATHOLOGICAL AND STEROID-HORMONE RECEPTORS CORRELATES, Diagnostic molecular pathology, 6(4), 1997, pp. 199-208
PREDICTION OF RESPONSE TO ANTIESTROGEN THERAPY IN ADVANCED BREAST-CANCER PATIENTS BY PRETREATMENT CIRCULATING LEVELS OF EXTRACELLULAR DOMAIN OF THE HER-2 C-NEU PROTEIN/
Authors: YAMAUCHI H ONEILL A GELMAN R CARNEY W TENNEY DY HOSCH S HAYES DF
Citation: H. Yamauchi et al., PREDICTION OF RESPONSE TO ANTIESTROGEN THERAPY IN ADVANCED BREAST-CANCER PATIENTS BY PRETREATMENT CIRCULATING LEVELS OF EXTRACELLULAR DOMAIN OF THE HER-2 C-NEU PROTEIN/, Journal of clinical oncology, 15(7), 1997, pp. 2518-2525
CONFORMATIONAL EFFECTS IN THE P53 PROTEIN OF MUTATIONS INDUCED DURINGCHEMICAL CARCINOGENESIS - MOLECULAR DYNAMIC AND IMMUNOLOGICAL ANALYSES
Authors: BRANDTRAUF PW CHEN JM MARION MJ SMITH SJ LUO JC CARNEY W PINCUS MR
Citation: Pw. Brandtrauf et al., CONFORMATIONAL EFFECTS IN THE P53 PROTEIN OF MUTATIONS INDUCED DURINGCHEMICAL CARCINOGENESIS - MOLECULAR DYNAMIC AND IMMUNOLOGICAL ANALYSES, Journal of protein chemistry, 15(4), 1996, pp. 367-375
IMMUNOHISTOCHEMICAL (IHC) DETECTION OF MUTANT P21RAS IN COLORECTAL ADENOMAS
Authors: COHEN S NIKULASSON S KUPCHIK H CARNEY W SCHROY P
Citation: S. Cohen et al., IMMUNOHISTOCHEMICAL (IHC) DETECTION OF MUTANT P21RAS IN COLORECTAL ADENOMAS, Gastroenterology, 110(4), 1996, pp. 505-505
THE MOLECULAR EPIDEMIOLOGY OF ONCOPROTEINS - SERUM P53 PROTEIN IN PATIENTS WITH ASBESTOSIS
Authors: HEMMINKI K PARTANEN R KOSKINEN H SMITH S CARNEY W BRANDTRAUF PW
Citation: K. Hemminki et al., THE MOLECULAR EPIDEMIOLOGY OF ONCOPROTEINS - SERUM P53 PROTEIN IN PATIENTS WITH ASBESTOSIS, Chest, 109(3), 1996, pp. 22-26
THE USE OF SPLICED VEIN BYPASSES FOR INFRAINGUINAL ARTERIAL RECONSTRUCTION - DISCUSSION
Authors: BELKIN M CHANG BB PANETTA TF CARNEY W RICOTTA JJ
Citation: M. Belkin et al., THE USE OF SPLICED VEIN BYPASSES FOR INFRAINGUINAL ARTERIAL RECONSTRUCTION - DISCUSSION, Journal of vascular surgery, 21(3), 1995, pp. 410-412
BCL-2 IN BREAST-CARCINOMA - ITS CORRELATION WITH ANDROGEN AND ESTROGEN-RECEPTOR STATUS AND OTHER HISTOLOGIC PROGNOSTIC FACTORS
Authors: DIAZCANO S GARCIAMOLINER M CARNEY W WOLFE HJ
Citation: S. Diazcano et al., BCL-2 IN BREAST-CARCINOMA - ITS CORRELATION WITH ANDROGEN AND ESTROGEN-RECEPTOR STATUS AND OTHER HISTOLOGIC PROGNOSTIC FACTORS, Laboratory investigation, 72(1), 1995, pp. 16-16
SERUM ONCOPROTEINS IN ASBESTOSIS PATIENTS
Authors: PARTANEN R KOSKINEN H OKSA P HEMMINKI K CARNEY W SMITH S BRANDTRAUF P
Citation: R. Partanen et al., SERUM ONCOPROTEINS IN ASBESTOSIS PATIENTS, Clinical chemistry, 41(12B), 1995, pp. 1844-1847
DETECTION OF SERUM P53 PROTEIN IN LUNG-CANCER PATIENTS
Authors: LUO JC ZEHAB R ANTTILA S RIDANPAA M HUSGAFVELPURSIAINEN K VAINIO H CARNEY W DEVIVO I MILLING C BRANDTRAUF PW
Citation: Jc. Luo et al., DETECTION OF SERUM P53 PROTEIN IN LUNG-CANCER PATIENTS, Journal of occupational medicine, 36(2), 1994, pp. 155-160
Risultati: 1-10 |